The iconic rise of Viagra has firmly established as a symbol of pharmaceutical success, however its position within the broader sector now presents questions about future gains. Alternative versions are undercutting market share, causing anxieties that supporting companies closely tied to Viagra's former standing could be a dangerous strategy, espe